Compare SUVEN LIFE with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES UNICHEM LAB SUVEN LIFESCIENCES/
UNICHEM LAB
 
P/E (TTM) x 19.8 61.1 32.4% View Chart
P/BV x 4.0 0.7 610.3% View Chart
Dividend Yield % 0.5 2.1 25.0%  

Financials

 SUVEN LIFESCIENCES   UNICHEM LAB
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
UNICHEM LAB
Mar-19
SUVEN LIFESCIENCES/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs338292 115.7%   
Low Rs169182 93.1%   
Sales per share (Unadj.) Rs52.1167.7 31.1%  
Earnings per share (Unadj.) Rs6.8-3.6 -188.1%  
Cash flow per share (Unadj.) Rs8.65.9 144.2%  
Dividends per share (Unadj.) Rs1.504.00 37.5%  
Dividend yield (eoy) %0.61.7 35.1%  
Book value per share (Unadj.) Rs65.3372.3 17.5%  
Shares outstanding (eoy) m127.2870.38 180.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.91.4 344.1%   
Avg P/E ratio x37.1-65.3 -56.9%  
P/CF ratio (eoy) x29.639.9 74.2%  
Price / Book Value ratio x3.90.6 610.0%  
Dividend payout %22.0-110.2 -19.9%   
Avg Mkt Cap Rs m32,27216,680 193.5%   
No. of employees `0001.12.6 41.6%   
Total wages/salary Rs m6612,393 27.6%   
Avg. sales/employee Rs Th6,132.24,535.2 135.2%   
Avg. wages/employee Rs Th611.1919.8 66.4%   
Avg. net profit/employee Rs Th803.5-98.2 -818.2%   
INCOME DATA
Net Sales Rs m6,63511,801 56.2%  
Other income Rs m242984 24.6%   
Total revenues Rs m6,87712,785 53.8%   
Gross profit Rs m1,604-835 -192.1%  
Depreciation Rs m221674 32.9%   
Interest Rs m3875 50.1%   
Profit before tax Rs m1,587-600 -264.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-343 -209.0%   
Profit after tax Rs m869-256 -340.2%  
Gross profit margin %24.2-7.1 -341.7%  
Effective tax rate %45.257.3 79.0%   
Net profit margin %13.1-2.2 -605.1%  
BALANCE SHEET DATA
Current assets Rs m6,23220,384 30.6%   
Current liabilities Rs m1,4905,029 29.6%   
Net working cap to sales %71.5130.1 54.9%  
Current ratio x4.24.1 103.2%  
Inventory Days Days86105 82.5%  
Debtors Days Days83135 61.2%  
Net fixed assets Rs m4,0439,023 44.8%   
Share capital Rs m127141 90.4%   
"Free" reserves Rs m8,18326,058 31.4%   
Net worth Rs m8,31026,199 31.7%   
Long term debt Rs m180-   
Total assets Rs m10,38931,496 33.0%  
Interest coverage x43.1-7.0 -618.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.4 170.5%   
Return on assets %8.7-0.6 -1,525.0%  
Return on equity %10.5-1.0 -1,072.7%  
Return on capital %19.5-2.0 -976.1%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6228,188 68.7%   
Fx outflow Rs m1,799596 301.9%   
Net fx Rs m3,8227,592 50.3%   
CASH FLOW
From Operations Rs m356-3,278 -10.8%  
From Investments Rs m-279-2,860 9.7%  
From Financial Activity Rs m-225-24 930.2%  
Net Cashflow Rs m-148-4,690 3.2%  

Share Holding

Indian Promoters % 63.4 50.1 126.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 31.7 115.1%  
Shareholders   37,287 20,176 184.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare SUVEN LIFESCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend, Developments From the IPO Space, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets fell sharply during closing hours amid fears of rising crude oil prices and weakness in the rupee.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Sep 17, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS